The objective: Evaluation of fetal and neonatal immediate impact of pregnancy hypertensive disease, and a comparison between the severity of gestational hypertensive disease and neonatal outcome.
Materials and Methods This work was based on the analysis of the neonatology registers of the maternity service in Rabat’s university hospital during 2010. we selected the newborns from mothers with gestational hypertension, and we clarified the evolutionary stage of this disease. A standardized form of farm has been established for this purpose.
Results 560 newborns meeted the analysis criteria, that is 3.69% of all newborns during this period. The average age of the parturients was 28±12 years. Delivery has been advocated by Caesarean in 53.2% of cases, perinatal asphyxia was associated in 12.8% of cases. The prematurity rate was 16.8%. The hyportrophy was observed in 44% and macrosomia in 3% of cases. Fetal mortality was observed in 10.7% of cases.
The péeclampsie represents 28.5% of cases, and retroplacental hematoma which is the most frequent maternal complication was 9.1%. Mortality and neonatal morbidity changes depending on maternal complications. Mortality and neonatal morbidity vary significantly according to maternal complications. In this study, the retroplacental hematoma, the helpp syndrome and eclampsia are responsible for a high rate of fetal mortality (27.5%), neonatal mortality (12%) and perinatal asphyxia (39.6%) compared to preeclampsia and uncomplicated gestational hypertension.
Conclusion There is a clear correlation between the stage of the gestational hypertension evolution and the newborn’s prognosis. The latter can be improved by a correct maternal prenatal monitoring.